Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FK361
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,815
Award facts
- Contract value 100% obligated
- $29,814.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,814.60 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is delivering the product to its corporate office location in Conshohocken, PA. Dupixent is a specialty biologic medication used to treat various inflammatory conditions, and this order represents one of numerous pharmaceutical procurements that AmerisourceBergen fulfills through the DLA supply chain.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's extensive portfolio of federal medical product deliveries, coupled with its demonstrated capability to compete successfully for open contracts, positions it as a critical vendor for federal pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FK361?
SPE2DR26FK361 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FK361 worth?
The government has obligated $29,815 on SPE2DR26FK361.
Is contract SPE2DR26FK361 an order under another contract?
Yes. SPE2DR26FK361 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK361 competed?
The extent of competition for SPE2DR26FK361 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award